Your browser doesn't support javascript.
loading
Synthesis and biological evaluation of substituted pyrrolidines and pyrroles as potential anticancer agents.
Ji, Jiali; Sajjad, Farrukh; You, Qun; Xing, Dong; Fan, Hui; Reddy, Alavala G K; Hu, Wenhao; Dong, Suzhen.
Afiliação
  • Ji J; Shanghai Engineering Research Centre of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Sajjad F; Shanghai Engineering Research Centre of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • You Q; Shanghai Engineering Research Centre of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Xing D; Shanghai Engineering Research Centre of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Fan H; Shanghai Engineering Research Centre of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Reddy AGK; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Hu W; Shanghai Engineering Research Centre of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.
  • Dong S; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
Arch Pharm (Weinheim) ; 353(12): e2000136, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32776576
ABSTRACT
A series of polysubstituted pyrrolidines obtained via ruthenium-catalyzed cascade cyclization of diazo pyruvates and anilines as well as their corresponding pyrrole analogs obtained via dehydration were evaluated for their antiproliferation activities. Pyrrolidines 3h and 3k showed good proliferation inhibitory effects toward 10 cancer cell lines with IC50 values ranging from 2.9 to 16 µM. Furthermore, pyrrolidine 3k induced cell cycle arrest at the G0/G1 phase and time- and dose-dependent cellular apoptosis in both HCT116 and HL60 cells, suggesting that this type of pyrrolidine structure might be a good candidate for future anticancer therapies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Pirrolidinas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirróis / Pirrolidinas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China